Citations for
1AMKLDS, JAK2
Prevalence and clinical correlates of JAK2 mutations in Down syndrome acute lymphoblastic leukaemia.
Gaikwad A, Rye CL, Devidas M, Heerema NA, Carroll AJ, Izraeli S, Plon SE, Basso G, Pession A, Rabin KR.
Br J Haematol 144(6):930-2. Epub 2008 Dec 20. 2009
2AMKLDS, KS, MVA1, TRI18, TRI21, TRI8, TS
Constitutional aneuploidy and cancer predisposition.
Ganmore I, Smooha G, Izraeli S.
Hum Mol Genet 18(R1):R84-93. 2009
3AMKLDS, JAK2
Specific JAK2 mutation (JAK2R683) and multiple gene deletions in Down syndrome acute lymphoblastic leukemia.
Kearney L, Gonzalez De Castro D, Yeung J, Procter J, Horsley SW, Eguchi-Ishimae M, Bateman CM, Anderson K, Chaplin T, Young BD, Harrison CJ, Kempski H, So CW, Ford AM, Greaves M.
Blood 113(3):646-8. Epub 2008 Oct 16. 2009
4AMKLDS, GATA1, TAM, TRI21
Natural history of GATA1 mutations in Down syndrome.
Ahmed M, Sternberg A, Hall G, Thomas A, Smith O, O'Marcaigh A, Wynn R, Stevens R, Addison M, King D, Stewart B, Gibson B, Roberts I, Vyas P.
Blood 103(7):2480-9. Epub 2003 Dec 4. 2004
5AMKLDS, GATA1, TAM, TRI21
Acquired mutations in GATA1 in neonates with Down's syndrome with transient myeloid disorder.
Groet J, McElwaine S, Spinelli M, Rinaldi A, Burtscher I, Mulligan C, Mensah A, Cavani S, Dagna-Bricarelli F, Basso G, Cotter FE, Nizetic D.
Lancet 361(9369):1617-20. 2003
6AMKLDS, GATA1, TAM, TRI21
Frequent mutations in the GATA-1 gene in the transient myeloproliferative disorder of Down syndrome.
Xu G, Nagano M, Kanezaki R, Toki T, Hayashi Y, Taketani T, Taki T, Mitui T, Koike K, Kato K, Imaizumi M, Sekine I, Ikeda Y, Hanada R, Sako M, Kudo K, Kojima S, Ohneda O, Yamamoto M, Ito E.
Blood 102(8):2960-8. Epub 2003 Jun 19. 2003
7AMKLDS, GATA1, TAM, TRI21
Mutagenesis of GATA1 is an initiating event in Down syndrome leukemogenesis.
Mundschau G, Gurbuxani S, Gamis AS, Greene ME, Arceci RJ, Crispino JD.
Blood 101(11):4298-300. Epub 2003 Jan 30. 2003